{"paper_id":"cf9cddf8-a43d-48d6-9321-379ed90a8e9f","body_text":"Document Type : Research Articles\nAuthors\n- Heidarali Esmaeili 1\n- Amir Vahedi 2\n- Shiva Mohajeri 3\n- Elmira Mostafidi 2\n- Mahzad Azimpouran 4\n- Mohammad Naghavi-Behzad 5\n1 Associate Professor of Pathology, Departments of Pathology, Imam Reza Teaching Hospital, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran\n2 Assistant Professor of Pathology, Departments of Pathology, Imam Reza Teaching Hospital, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran\n3 Resident of Pathology, Departments of Pathology, Imam Reza Teaching Hospital, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran\n4 Resident of pathology, Tabriz university of medical science, Tabriz,Iran\n5 Studens’ Research Committee, Tabriz University of Medical Science, Tabriz, Iran\nAbstract\nObjective: Endometriosis, one of the most common estrogen dependent gynecological disorders, can present as both benign and malignant disease. The prevalence of tumoral transformation is 0.7-1.6% and the most common tumors are clear cell and endometrioid carcinomas. Unfortunately, the pathogenesis of transformation is unknown. For this purpose, we examined molecular alterations in ovarian endometriosis and endometriosis-associated tumors. Methods: Using the data bank of Alzahra hospital pathology department and paraffin blocks from appropriate cases were identified. Sections were cut and stained for 3 markers: estrogen receptor, P53 and bcl2. Correlations between findings were investigated. Results: Nineteen cases of endometriosis-associated tumor and 19 cases of endometriosis were identified. Staining for bcl2 was documented in 14 of 19 (73.7%) of endometriosis-associated tumor cases and also 7 of 19 (36.8%) endometriosis cases (P=0.02). Only 3 of the 19 (15.8%) endometriosis-associated tumors exhibited positive staining for estrogen receptors, compared with 14 of 19 (73.7%) endometriosis cases (P<0.001). Positive staining for P53 was noted in 5 of 19 (31.6%) endometriosis-associated ovarian tumor samples but was absent in endometriosis samples (0%), (P =0.008). Conclusions: Endometriosis-associated tumors appear to be associated with overexpression of bcl2 and P53 and reduced expression of Estrogen receptor. These finding may help to diagnose tumoral transformation with a background of endometriosis.\nKeywords\nMain Subjects\nDecember 2016\nPages 5247-5250\n- Receive Date: 07 September 2016\n- Revise Date: 30 December 2016\n- Accept Date: 24 January 2017","source_license":"CC0","license_restricted":false}